Terms: = Testicular cancer AND BRD4, O60885, 23476, ENSG00000141867, HUNKI, CAP, MCAP
20 results:
1. Privileged Scaffolds Targeting Bromodomain-containing Protein 4.
Wang R; Wang YA; Xu YG; Shi L
Curr Top Med Chem; 2022; 22(7):600-627. PubMed ID: 35139799
[TBL] [Abstract] [Full Text] [Related]
2. Imaging spectrum of NUT carcinomas.
Virarkar M; Saleh M; Ramani NS; Morani AC; Bhosale P
Clin Imaging; 2020 Nov; 67():198-206. PubMed ID: 32866821
[TBL] [Abstract] [Full Text] [Related]
3. Borderline Mucinous testicular Tumour: Diagnostic and Management difficulties.
Pratap K; Perera M; Malczewski F; Esler R
BMJ Case Rep; 2018 Oct; 2018():. PubMed ID: 30287624
[TBL] [Abstract] [Full Text] [Related]
4. XAGE-1b cancer/testis antigen is a potential target for immunotherapy in prostate cancer.
Xie C; Wang G
Urol Int; 2015; 94(3):354-62. PubMed ID: 25572590
[TBL] [Abstract] [Full Text] [Related]
5. Concept and viability of androgen annihilation for advanced prostate cancer.
Mohler JL
Cancer; 2014 Sep; 120(17):2628-37. PubMed ID: 24771515
[TBL] [Abstract] [Full Text] [Related]
6. Androgen deprivation induces rapid involution and recovery of human prostate vasculature.
Godoy A; Montecinos VP; Gray DR; Sotomayor P; Yau JM; Vethanayagam RR; Singh S; Mohler JL; Smith GJ
Am J Physiol Endocrinol Metab; 2011 Feb; 300(2):E263-75. PubMed ID: 20699437
[TBL] [Abstract] [Full Text] [Related]
7. A novel communication role for CYP17A1 in the progression of castration-resistant prostate cancer.
Locke JA; Fazli L; Adomat H; Smyl J; Weins K; Lubik AA; Hales DB; Nelson CC; Gleave ME; Tomlinson Guns ES
Prostate; 2009 Jun; 69(9):928-37. PubMed ID: 19267349
[TBL] [Abstract] [Full Text] [Related]
8. BRD-NUT oncoproteins: a family of closely related nuclear proteins that block epithelial differentiation and maintain the growth of carcinoma cells.
French CA; Ramirez CL; Kolmakova J; Hickman TT; Cameron MJ; Thyne ME; Kutok JL; Toretsky JA; Tadavarthy AK; Kees UR; Fletcher JA; Aster JC
Oncogene; 2008 Apr; 27(15):2237-42. PubMed ID: 17934517
[TBL] [Abstract] [Full Text] [Related]
9. The effects of short-term oral phytoestrogen supplementation on the hypothalamic-pituitary-testicular axis in prostate cancer patients.
Rannikko A; Petas A; Raivio T; Jänne OA; Rannikko S; Adlercreutz H
Prostate; 2006 Jul; 66(10):1086-91. PubMed ID: 16637075
[TBL] [Abstract] [Full Text] [Related]
10. [Hormonal therapy for prostatic cancer--state of the art].
Miyakita H
Nihon Rinsho; 2005 Feb; 63(2):305-8. PubMed ID: 15714983
[TBL] [Abstract] [Full Text] [Related]
11. Androgen receptor up-regulates insulin-like growth factor binding protein-5 (IGFBP-5) expression in a human prostate cancer xenograft.
Gregory CW; Kim D; Ye P; D'Ercole AJ; Pretlow TG; Mohler JL; French FS
Endocrinology; 1999 May; 140(5):2372-81. PubMed ID: 10218991
[TBL] [Abstract] [Full Text] [Related]
12. Androgen receptor expression in androgen-independent prostate cancer is associated with increased expression of androgen-regulated genes.
Gregory CW; Hamil KG; Kim D; Hall SH; Pretlow TG; Mohler JL; French FS
Cancer Res; 1998 Dec; 58(24):5718-24. PubMed ID: 9865729
[TBL] [Abstract] [Full Text] [Related]
13. Complete androgen blockade versus chemical castration in advanced prostatic cancer: analysis of an Italian multicentre study. Italian Leuprorelin Group.
Bono AV; DiSilverio F; Robustelli della Cuna G; Benvenuti C; Brausi M; Ferrari P; Gibba A; Galli L
Urol Int; 1998; 60 Suppl 1():18-24. PubMed ID: 9563140
[TBL] [Abstract] [Full Text] [Related]
14. Treatment of metastatic carcinoma of the prostate.
Goethuys H; Baert L; Van Poppel H; Lieskovsky G; Brady LW; Petrovich Z
Am J Clin Oncol; 1997 Feb; 20(1):40-5. PubMed ID: 9020286
[TBL] [Abstract] [Full Text] [Related]
15. Translation initiation on the insulin-like growth factor II leader 1 is developmentally regulated.
Teerink H; Kasperaitis MA; De Moor CH; Voorma HO; Thomas AA
Biochem J; 1994 Oct; 303 ( Pt 2)(Pt 2):547-53. PubMed ID: 7980416
[TBL] [Abstract] [Full Text] [Related]
16. [Effects of recombinant human granulocyte colony-stimulating factor on superoxide production by neutrophil in cancer patients receiving chemotherapy].
Yoshida M; Oshi M; Aso Y; Yanagisawa R; Kishi H; Ishida Y
Nihon Hinyokika Gakkai Zasshi; 1993 Jul; 84(7):1262-8. PubMed ID: 7689123
[TBL] [Abstract] [Full Text] [Related]
17. [Influence of cytotoxic chemotherapy on superoxide production by neutrophils in cancer patients].
Yoshida M; Yanagisawa R; Ishida Y; Kishi H
Kansenshogaku Zasshi; 1993 Jan; 67(1):30-5. PubMed ID: 7680704
[TBL] [Abstract] [Full Text] [Related]
18. Prostate cancer in a 75-year-old man after four decades of testicular androgen deprivation.
Boccon-Gibod L; Dauge MC; Billebaud T; Sibert A; Baron JC; Nahoul K
Eur Urol; 1991; 20(1):81-4. PubMed ID: 1743239
[TBL] [Abstract] [Full Text] [Related]
19. Trophoblastic proteins as tumor markers in nonseminomatous germ cell tumors.
Braunstein GD; Thompson R; Princler GL; McIntire KR
Cancer; 1986 May; 57(9):1842-5. PubMed ID: 2420442
[TBL] [Abstract] [Full Text] [Related]
20. [Current status of combination chemotherapy].
Ogawa M
Gan To Kagaku Ryoho; 1986 Feb; 13(2):171-9. PubMed ID: 2418788
[TBL] [Abstract] [Full Text] [Related]
